Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Current Leases (2020 - 2025)

Maxcyte (MXCT) has disclosed Current Leases for 6 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 68.52% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 68.52% year-over-year, with the annual reading at $1.5 million for FY2025, 68.52% up from the prior year.
  • Current Leases for Q4 2025 was $1.5 million at Maxcyte, up from $1.3 million in the prior quarter.
  • The five-year high for Current Leases was $1.5 million in Q4 2025, with the low at $152200.0 in Q3 2022.
  • Average Current Leases over 5 years is $748347.4, with a median of $698700.0 recorded in 2023.
  • The sharpest move saw Current Leases tumbled 73.41% in 2022, then skyrocketed 392.99% in 2023.
  • Over 5 years, Current Leases stood at $527200.0 in 2021, then plummeted by 70.22% to $157000.0 in 2022, then soared by 392.99% to $774000.0 in 2023, then grew by 11.63% to $864000.0 in 2024, then surged by 68.52% to $1.5 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $1.5 million, $1.3 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.